netFormulary NHS
North Central London
Joint Formulary

Looking for Alemtuzumab found 4 matches

Open monograph to display formulary status BNF Category
  Restricted Drug Alemtuzumab  (Lemtrada)
(Multiple sclerosis)
Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
  Alemtuzumab Free-Of-Charge
Malignant disease and immunosuppression - Unlicensed Medicines / Significant off-label use - 08.04

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA202 (not recommended): Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab (08.02.03)
link in drug section NICE TA312: Alemtuzumab for relapsing‑remitting multiple sclerosis (08.02.03)